PreferredStockChannel
Dynavax Technologies Corp (DVAX)

Dynavax Technologies is a commercial stage biopharmaceutical company focused on developing and commercializing vaccines. Co.'s primary marketed product, HEPLISAV-B® (Hepatitis B Vaccine (Recombinant), Adjuvanted), is approved by the United States Food and Drug Administration for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults approved in the United States. Co. also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Co. developed CpG 1018 to provide an increased vaccine immune response, as demonstrated in HEPLISAV-B.

Name: 
Dynavax Technologies Corp
Website: 
www.dynavax.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding DVAX: 
25 (see which ones)
Total Market Value Held by ETFs: 
$186,949,074.8
Total Market Capitalization: 
$1,527,000,000
% of Market Cap. Held by ETFs: 
12.24%
Quotes delayed 20 minutes

Email EnvelopeFree DVAX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
92nd percentile
(ranked higher than approx. 92% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com
Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

Dynavax Technologies Corp (DVAX) Information Page | Preferred Stock Channel | www.PreferredStockChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.